The global lung cancer screening market is poised for significant growth in the coming years, driven by increasing awareness about the importance of early detection and advancements in screening technologies. According to a recent report released by [Research Firm/Institution], the lung cancer screening market was valued at USD 2.81 billion in 2022. It is expected to reach USD 5.13 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.8% over the forecast period of 2023-2030.
Lung cancer is one of the leading causes of cancer-related mortality worldwide, with a high mortality rate due to late-stage diagnosis. However, early detection through screening can significantly improve patient outcomes by enabling timely intervention and treatment. Lung cancer screening involves the use of imaging techniques such as low-dose computed tomography (LDCT) to detect lung nodules or abnormalities in high-risk individuals, such as current or former smokers.
Get Sample @ https://www.snsinsider.com/sample-request/3392
Key Players
The major key players are Koninklijke Philips, Siemens Healthcare, GE Healthcare, Canon Medical Systems, Medtronic, EON, PenRAD Technologies, Volpara Solutions Limited, Nuance Communications, Fujifilm Holdings Corporation and others.
Several factors are driving the growth of the lung cancer screening market, including:
-
Rising Incidence of Lung Cancer: The incidence of lung cancer continues to rise globally, driven by factors such as smoking, environmental pollution, and occupational exposure to carcinogens. The growing burden of lung cancer underscores the importance of early detection through screening programs, driving the demand for lung cancer screening technologies.
-
Advancements in Screening Technologies: Ongoing advancements in imaging technologies, such as LDCT, have improved the sensitivity and accuracy of lung cancer screening. These advancements enable the detection of lung nodules at earlier stages, facilitating timely diagnosis and treatment initiation, thereby driving market growth.
-
Increasing Awareness and Screening Initiatives: Public health initiatives and campaigns aimed at raising awareness about the importance of lung cancer screening and early detection are driving increased participation in screening programs. Healthcare providers and policymakers are emphasizing the need for targeted screening programs for high-risk populations, further fueling market growth.
-
Growing Adoption of Personalized Medicine: The emergence of personalized medicine approaches in oncology, including targeted therapies and immunotherapies, has highlighted the importance of early diagnosis and molecular profiling for treatment decision-making. Lung cancer screening can identify individuals who may benefit from targeted therapies based on the presence of specific molecular alterations, driving its adoption in clinical practice.
Key Market Segmentation
By Cancer Type
-
Non-Small Cell Lung Cancer
-
Small Cell Lung Cancer
By Diagnosis Type
-
Low Dose Spiral CT scan
-
Chest X-Ray
By End User
-
Hospitals & Clinics
-
Diagnostics Centres
The lung cancer screening market is characterized by the presence of several key players offering a range of screening technologies and services. Companies are investing in research and development to introduce innovative screening technologies and expand their market presence.
As the lung cancer screening market continues to evolve, stakeholders across the healthcare industry, including healthcare providers, screening centers, patient advocacy groups, and regulatory authorities, are encouraged to collaborate to ensure access to high-quality screening services for individuals at risk of lung cancer.
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com